These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37829941)

  • 1. Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project.
    Lee DH; Eichelberger GS; Patel V; Chhaya R; Khadilkar A; Bishop J; Bezerra H; Oliveira G; Matar F; Fernandez J
    Cureus; 2023 Sep; 15(9):e45024. PubMed ID: 37829941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
    Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
    JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
    Rosenblum H; Masri A; Narotsky DL; Goldsmith J; Hamid N; Hahn RT; Kodali S; Vahl T; Nazif T; Khalique OK; Bokhari S; Soman P; Cavalcante JL; Maurer MS; Castaño A
    Eur J Heart Fail; 2021 Feb; 23(2):250-258. PubMed ID: 32729170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
    Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
    ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.
    Gallone G; Bongiovanni C; Bruno F; Landra F; Andreis A; Fava A; Scudeler L; DE Filippo O; Califaretti E; Cioffi M; Pidello S; Vairo A; Raineri C; Frea S; Giorgi M; Alunni G; Casoni R; Salizzoni S; Conrotto F; D'Ascenzo F; Rinaldi M; DE Ferrari GM
    Minerva Cardiol Angiol; 2024 Feb; 72(1):87-94. PubMed ID: 37405712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR.
    Abadie B; Ali AH; Martyn T; Higgins A; Krishnaswamy A; Reed G; Puri R; Yun J; Cremer P; Hanna M; Tang WHW; Kapadia S; Jaber W
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3910-3916. PubMed ID: 37606857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
    Nitsche C; Koschutnik M; Donà C; Radun R; Mascherbauer K; Kammerlander A; Heitzinger G; Dannenberg V; Spinka G; Halavina K; Winter MP; Calabretta R; Hacker M; Agis H; Rosenhek R; Bartko P; Hengstenberg C; Treibel T; Mascherbauer J; Goliasch G
    Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014115. PubMed ID: 35861981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATTR Amyloidosis: Current and Emerging Management Strategies:
    Griffin JM; Rosenthal JL; Grodin JL; Maurer MS; Grogan M; Cheng RK
    JACC CardioOncol; 2021 Oct; 3(4):488-505. PubMed ID: 34729521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
    Dobner S; Pilgrim T; Hagemeyer D; Heg D; Lanz J; Reusser N; Gräni C; Afshar-Oromieh A; Rominger A; Langhammer B; Reineke D; Windecker S; Stortecky S
    J Am Heart Assoc; 2023 Aug; 12(16):e030271. PubMed ID: 37581394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis.
    Cannata F; Chiarito M; Pinto G; Villaschi A; Sanz-Sánchez J; Fazzari F; Regazzoli D; Mangieri A; Bragato RM; Colombo A; Reimers B; Condorelli G; Stefanini GG
    ESC Heart Fail; 2022 Oct; 9(5):3188-3197. PubMed ID: 35770333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wild-type transthyretin-related cardiac amyloidosis and degenerative aortic stenosis: Two inter-related pathologies in the elderly].
    Calero Núñez S; Tercero Martínez A; García López JC; Jiménez-Mazuecos J
    Rev Esp Geriatr Gerontol; 2017; 52(3):167-170. PubMed ID: 27292540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
    Nitsche C; Scully PR; Patel KP; Kammerlander AA; Koschutnik M; Dona C; Wollenweber T; Ahmed N; Thornton GD; Kelion AD; Sabharwal N; Newton JD; Ozkor M; Kennon S; Mullen M; Lloyd G; Fontana M; Hawkins PN; Pugliese F; Menezes LJ; Moon JC; Mascherbauer J; Treibel TA
    J Am Coll Cardiol; 2021 Jan; 77(2):128-139. PubMed ID: 33181246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
    Gallone G; Landra F; D'Ascenzo F; Conrotto F; Casoni R; Bruno F; Omedè P; Alunni G; Andreis A; Vairo A; Giorgi M; Fava A; De Ferrari GM
    BMC Cardiovasc Disord; 2020 Jun; 20(1):261. PubMed ID: 32487051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive study of the clinical and myocardial status of a population with anatomopathological aortic valve amyloidosis.
    Brette JB; Colombat M; Fournier P; Moninhas M; Marcheix B; Lairez O; Cariou E;
    Cardiovasc Pathol; 2024 Jul; ():107674. PubMed ID: 39025343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Amyloidosis in Patients Undergoing TAVR: Why We Need to Think About It.
    Cappelli F; Perfetto F; Martone R; Di Mario C
    Cardiovasc Revasc Med; 2021 Jan; 22():109-114. PubMed ID: 32571759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
    Patel KP; Scully PR; Nitsche C; Kammerlander AA; Joy G; Thornton G; Hughes R; Williams S; Tillin T; Captur G; Chacko L; Kelion A; Sabharwal N; Newton JD; Kennon S; Ozkor M; Mullen M; Hawkins PN; Gillmore JD; Menezes L; Pugliese F; Hughes AD; Fontana M; Lloyd G; Treibel TA; Mascherbauer J; Moon JC
    Heart; 2022 Jan; 108(1):67-72. PubMed ID: 34497140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
    Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
    Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients.
    Scully PR; Patel KP; Saberwal B; Klotz E; Augusto JB; Thornton GD; Hughes RK; Manisty C; Lloyd G; Newton JD; Sabharwal N; Kelion A; Kennon S; Ozkor M; Mullen M; Hartman N; Cavalcante JL; Menezes LJ; Hawkins PN; Treibel TA; Moon JC; Pugliese F
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2177-2189. PubMed ID: 32771574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A wolf in sheep's clothing-aortic stenosis and cardiac amyloidosis: "RAISE"ing awareness in clinical practice.
    Sabbour H; Al-Humood K; Al Taha Z; Romany I; Haddadin H; Mohty D
    Front Cardiovasc Med; 2024; 11():1323023. PubMed ID: 38464842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native T1 mapping in transthyretin amyloidosis.
    Fontana M; Banypersad SM; Treibel TA; Maestrini V; Sado DM; White SK; Pica S; Castelletti S; Piechnik SK; Robson MD; Gilbertson JA; Rowczenio D; Hutt DF; Lachmann HJ; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):157-65. PubMed ID: 24412190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.